Evidence map›Paper›PMID 27614896›Full record

Trial reportPsychopharmacology2016

Oxytocin modulates hemodynamic responses to monetary incentives in humans.

Brian J Mickey, Joseph Heffernan, Curtis Heisel, Marta Peciña, David T Hsu, Jon-Kar Zubieta, Tiffany M Love

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Psychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Effects of Intranasal Oxytocin on the Blood Oxygenation Level-Dependent Signal in Food Motivation and Cognitive Control Pathways in Overweight and Obese Men.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Trial
  4. How does oxytocin modulate human behavior?Molecular psychiatry · 2025
    Review
  5. Neuropeptidergic systems in psychiatric disorders.Frontiers in endocrinology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Neuropeptide Y and representation of salience in human nucleus accumbens.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Brian J MickeyDepartment of Psychiatry, University of Michigan Medical School, Ann Arbor, MI, USA.
Joseph HeffernanMolecular and Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, MI, USA.
Curtis HeiselMolecular and Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, MI, USA.
Marta PeciñaDepartment of Psychiatry, University of Michigan Medical School, Ann Arbor, MI, USA.
David T HsuDepartment of Psychiatry, University of Michigan Medical School, Ann Arbor, MI, USA.
Jon-Kar ZubietaDepartment of Psychiatry, University of Michigan Medical School, Ann Arbor, MI, USA.
Tiffany M LoveDepartment of Psychiatry, University of Michigan Medical School, Ann Arbor, MI, USA. tiffany.love@hsc.utah.edu.
University of Michigan–Ann Arbor · USStony Brook Medicine · USUniversity of Utah · US

Funding

MICHIGAN INSTITUTE FOR CLINICAL AND HEALTH RESEARCH (MICHR) (UL1): (BPCA)UL1RR024986 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHANLEY, THOMAS P. · 2007 to 2011
$51.2M
Michigan Institute for Clinical and Health Research (MCHR)UL1TR000433 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$49.9M
Michigan Institute for Clinical and Health Research (MICHR) (KL2)KL2RR024987 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHANLEY, THOMAS P. · 2007 to 2011
$2.8M
Michigan Institute for Clinical and Health Research (MCHR)KL2TR000434 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$1.7M
Defining and manipulating social neural systems in alcohol use disorderK01AA024167 · NIAAA · UNIVERSITY OF UTAH · PI LOVE, TIFFANY · 2015 to 2019
$805k
Functional Neuroimaging of Individual Differences in Affect and Motivation in MajK23MH092648 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MICKEY, BRIAN JAMES · 2012 to 2015
$729k
NCATS NIH HHS KL2 TR000434NCATS NIH HHS UL1 TR000433NCRR NIH HHS KL2 RR024987NCRR NIH HHS UL1 RR024986NIAAA NIH HHS K01 AA024167NIMH NIH HHS K23 MH092648
6 · The paper itself

Abstract

rationaleOxytocin is a neuropeptide widely recognized for its role in regulating social and reproductive behavior. Increasing evidence from animal models suggests that oxytocin also modulates reward circuitry in non-social contexts, but evidence in humans is lacking.

objectivesWe examined the effects of oxytocin administration on reward circuit function in 18 healthy men as they performed a monetary incentive task.

methodsThe blood oxygenation level-dependent (BOLD) signal was measured using functional magnetic resonance imaging in the context of a randomized, double-blind, placebo-controlled, crossover trial of intranasal oxytocin.

resultsWe found that oxytocin increases the BOLD signal in the midbrain (substantia nigra and ventral tegmental area) during the late phase of the hemodynamic response to incentive stimuli. Oxytocin's effects on midbrain responses correlated positively with its effects on positive emotional state. We did not detect an effect of oxytocin on responses in the nucleus accumbens. Whole-brain analyses revealed that oxytocin attenuated medial prefrontal cortical deactivation specifically during anticipation of loss.

conclusionsOur findings demonstrate that intranasal administration of oxytocin modulates human midbrain and medial prefrontal function during motivated behavior. These findings suggest that endogenous oxytocin is a neurochemical mediator of reward behaviors in humans-even in a non-social context-and that the oxytocinergic system is a potential target of pharmacotherapy for psychiatric disorders that involve dysfunction of reward circuitry.

Indexed as

RewardAdministration, IntranasalAdultAnalysis of VarianceAnimalsDouble-Blind MethodEmotionsHemodynamicsHumansMagnetic Resonance ImagingMaleMesencephalonMotivationNucleus AccumbensOxygenOxytocicsOxygenOxytocicsOxytocinFMRIOxytocinReward

Identifiers

PMID27614896
PMCPMC5106343
OpenAlexW2518654230

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.